2006
DOI: 10.1039/b515328j
|View full text |Cite
|
Sign up to set email alerts
|

The mechanism of action of ramoplanin and enduracidin

Abstract: The lipoglycodepsipeptide antibiotic ramoplanin is proposed to inhibit bacterial cell wall biosynthesis by binding to intermediates along the pathway to mature peptidoglycan, which interferes with further enzymatic processing. Two sequential enzymatic steps can be blocked by ramoplanin, but there is no definitive information about whether one step is inhibited preferentially. Here we use inhibition kinetics and binding assays to assess whether ramoplanin and the related compound enduracidin have an intrinsic p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
98
0
1

Year Published

2006
2006
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 118 publications
(102 citation statements)
references
References 31 publications
3
98
0
1
Order By: Relevance
“…The failure of the sugars to adopt a well-ordered conformation argues against any critical role for them, and in fact they do not contribute to antimicrobial activity or Lipid II binding (16,21,22,26). Indeed, the structurally related depsipeptide antibiotic enduracidin contains no carbohydrate, yet has comparable activity to that of ramoplanin (9,12). Hence, it appears that the sugars contribute mainly to solubility and help define the amphipathic nature of the molecule.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The failure of the sugars to adopt a well-ordered conformation argues against any critical role for them, and in fact they do not contribute to antimicrobial activity or Lipid II binding (16,21,22,26). Indeed, the structurally related depsipeptide antibiotic enduracidin contains no carbohydrate, yet has comparable activity to that of ramoplanin (9,12). Hence, it appears that the sugars contribute mainly to solubility and help define the amphipathic nature of the molecule.…”
Section: Resultsmentioning
confidence: 99%
“…At least three forms are known, A1, A2, and A3; these forms differ in their acyl chain substituents, but possess essentially identical antibiotic activities. Ramoplanins are structurally and functionally related to ramoplanose, which is produced by Actinoplanes strain U.K.-71,903 and which differs from factor A2 by one mannose unit (7), and to enduracidin A and B, which are produced by Streptomyces fungicidicus B5477 (8)(9)(10). This paper focuses on the ramoplanin A2 isomer, the most abundant among the A1-A3 forms; for simplicity's sake, we refer to this isomer as ramoplanin for the remainder of the manuscript.…”
mentioning
confidence: 99%
“…Cell-wall synthesis comprises the formation of glycan strands (transglycosylation) and peptide cross-links between them (transpeptidation). We thus treated cells with the previously characterized transglycosylation substrate inhibitor ramoplanin (17) and the transpeptidation substrate inhibitor vancomycin (18) [for effective drug treatment we used a lptD4213 mutant (19,20) with increased outer-membrane-permeability]. Here, we propose that the transmembrane cell-wall synthesis complex (yellow) acts in the periplasm (between the cyan outer membrane and peach inner membrane) to polymerize glycan strands (green) and form peptide cross-links (orange) to incorporate the strands into the existing peptidoglycan network, thereby causing the associated MreB filaments (magenta) to rotate in the cytoplasm.…”
Section: Resultsmentioning
confidence: 99%
“…11 We have recently applied a tailor-made methodology of cell wall digestion and regeneration to the uncommon actinomycete Planobispora rosea, with the aim of improving its production of the thiazolyl peptide antibiotic GE2270 by genome shuffling. 12 In this paper, we have extended the use of this approach to actinomycete species, which produce valuable antibiotics already in clinical use or under development (teicoplanin, 13 A40926-precursor of the semisynthetic dalbavancin-, 14,15 ramoplanin 16 enduracidin 17,18 ) or potentially interesting molecules to be used per se or as scaffold for new drugs 19,20 ( Table 1). The different response to protoplast treatment has been correlated with the diversity of peptidoglycan precursors in representative strains.…”
Section: Introductionmentioning
confidence: 99%